One million dollars is about to go a long way for Ann Arbor's Accord
Biomaterials. The firm just received $1 million in venture capital to develop
its latest coating for medical devices.Excerpt:
And the first round goes to Accord Biomaterials. The Ann
Arbor-based firm that makes coatings for medical devices has raised $1 million
in venture capital to develop its newest product.
The financing is provided by a number of local venture
capital firms, including Arboretum Ventures, Sigvion
Capital and the University
of Michigan’s Wolverine Venture Fund. The money
will help Accord Biomaterials, which works closely with the University of Michigan and MC3 Corp., advance its Nogen nitric
oxide technology, which improves the biocompatibility of medical devices.
Read the rest of the story here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.